Cigna Stock News

Cigna's stock drop after Q2 2025 is overdone; shares now trade at a 15% discount to their 5-year average, creating a compelling entry point. Despite mixed Q2 results and lower profit growth forecasts, my DCF model supports a fair value of $315 per share, implying 8.5% upside. Aggressive share buybacks and steady dividend growth enhance shareholder returns, while Cigna maintains strong cash flow...

Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds impacting peers like UnitedHealth Group. However, the stock price has fallen alongside UNH. Recent earnings were strong, guidance was affirmed, and valuation is attractive, with Wall Street seeing up to 35% upside potential. Risks remain from medical inflation and PBM regulatory scrutiny, but Cign...

Cigna (CI) Q2 Revenue Jumps 11%

Cigna beat Wall Street estimates for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business.

The Cigna Group (NYSE:CI ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Ann M. Dennison - Executive VP & CFO Brian C.

The Cigna Group reported a second quarter profit of $1.5 billion as its Evernorth health service business performs well and despite rising costs in its employer health benefits business.

Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business.

Total revenues for the second quarter 2025 increased 11% to $67.2 billion Shareholders' net income for the second quarter 2025 was $1.5 billion, or $5.71 per share Adjusted income from operations1 for the second quarter 2025 was $1.9 billion, or $7.20 per share Reaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2 BLOOMFIELD, Conn. , July 31, 2025 /PRNewswi...